John Robinson
2023
In 2023, John Robinson earned a total compensation of $3M as Chief Scientific Officer at Cogent Biosciences, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $245,565 |
|---|---|
| Option Awards | $1,512,416 |
| Salary | $491,130 |
| Stock Awards | $713,600 |
| Other | $13,200 |
| Total | $2,975,911 |
Robinson received $1.5M in option awards, accounting for 51% of the total pay in 2023.
Robinson also received $245.6K in bonus, $491.1K in salary, $713.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, John Robinson's compensation ranked 310th out of 2,978 executives tracked by ExecPay. In other words, Robinson earned more than 89.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 310 out of 2,978 | 90th |
Division Manufacturing | 170 out of 1,637 | 90th |
Major group Chemicals And Allied Products | 114 out of 906 | 87th |
Industry group Drugs | 111 out of 869 | 87th |
Industry Pharmaceutical Preparations | 70 out of 627 | 89th |
Source: SEC filing on April 23, 2024.
Robinson's colleagues
We found two more compensation records of executives who worked with John Robinson at Cogent Biosciences in 2023.